News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AHF: Gilead Sciences, Inc. (GILD) Asks SEC To Block CEO Pay Resolution



1/15/2014 9:05:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) President and Gilead Sciences stockholder Michael Weinstein has written to the Securities and Exchange Commission (SEC) asking the SEC to deny Gilead’s recent request to exclude a shareholder proposal submitted by Weinstein to Gilead that was intended to be included in its Proxy for shareholder vote during Gilead’s 2014 Annual Meeting in May. Late last year, Weinstein submitted a shareholder proposal titled, “Patient Access as a Criterion of Executive Compensation,” for consideration for shareholder vote in conjunction with the 2014 Annual Meeting. The proposal would tie executive compensation to Gilead to the affordability and availability of its lifesaving medications.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES